These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 6850570)

  • 61. Effect of azathiopurine and OK-432 on urinary bladder carcinogenesis in rats.
    Cohen SM; Fukushima S; Tsuda H; Murasaki G; Ito N
    Gan; 1978 Dec; 69(6):773-9. PubMed ID: 750272
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Failure to activate Epstein-Barr virus genome in a latently-infected human lymphoblastoid cell line with urine containing a bladder carcinogenesis promoter].
    Fujita J; Yoshida O
    Hinyokika Kiyo; 1984 Jul; 30(7):897-901. PubMed ID: 6095626
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Promoting effect of monosodium aspartate, but not glycine, on renal pelvis and urinary bladder carcinogenesis in rat induced by N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Kitamura M; Konishi N; Kitahori Y; Fukushima Y; Yoshioka N; Hiasa Y
    Toxicol Pathol; 1996; 24(5):573-9. PubMed ID: 8923678
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Enhanced immunoreactivity of ras oncogene p21 protein in urinary bladder epithelium of rats treated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide.
    Masui T; Ward JM; Cohen SM
    Cancer Lett; 1991 Aug; 59(2):95-102. PubMed ID: 1884376
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of three sweeteners on rat urinary bladder carcinogenesis initiated by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
    Hagiwara A; Fukushima S; Kitaori M; Shibata M; Ito N
    Gan; 1984 Sep; 75(9):763-8. PubMed ID: 6500232
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Soft agar colony formation of bladder cells during carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine and application to detection of bladder cancer promoters.
    Hashimura T; Kanamaru H; Yoshida O
    Jpn J Cancer Res; 1987 May; 78(5):473-9. PubMed ID: 3112059
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Evaluation of nitrofurantoin on the two stages of urinary bladder carcinogenesis in the rat.
    Hasegawa R; Murasaki G; St John MK; Zenser TV; Cohen SM
    Toxicology; 1990 Jun; 62(3):333-47. PubMed ID: 2117780
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Metabolism and disposition of bladder carcinogens in rat and guinea pig: possible mechanism of guinea pig resistance to bladder cancer.
    Dawley RM; Zenser TV; Mattammal MB; Lakshmi VM; Hsu FF; Davis BB
    Cancer Res; 1991 Jan; 51(2):514-20. PubMed ID: 1898713
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dose-dependent promoting effect of trisodium nitrilotriacetate monohydrate on urinary bladder carcinogenesis in Wistar rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
    Kitahori Y; Konishi N; Shimoyama T; Hiasa Y
    Jpn J Cancer Res; 1985 Sep; 76(9):818-22. PubMed ID: 3932279
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Multistage carcinogenesis in the urinary bladder.
    Cohen SM; Greenfield RE; Ellwein LB
    Environ Health Perspect; 1983 Mar; 49():209-15. PubMed ID: 6832093
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Effect of aspirin on urinary bladder carcinogenesis initiated with N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats.
    Cohen SM; Hasegawa R; Sakata T; Johansson SL
    Cancer Res; 1989 Jan; 49(2):372-7. PubMed ID: 2491954
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Drugs, food additives and natural products as promoters in rat urinary bladder carcinogenesis.
    Ito N; Fukushima S; Shirai T; Hagiwara A; Imaida K
    IARC Sci Publ; 1984; (56):399-407. PubMed ID: 6536604
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Production of urinary tract tumors by co-administration of uracil and N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide in F344 rats.
    Wang CY; Kamiryo Y; Hayashida S; Croft WA
    Cancer Lett; 1987 Mar; 34(3):249-55. PubMed ID: 3828979
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Enhancement of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced carcinogenesis by urinary tract infection in rats.
    Johansson SL; Anderström C; von Schultz L; Larsson P
    Cancer Res; 1987 Jan; 47(2):559-62. PubMed ID: 3539325
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Pathological analysis of the carcinogenicity of sodium o-phenylphenate and o-phenylphenol.
    Fukushima S; Kurata Y; Ogiso T; Okuda M; Miyata Y; Ito N
    Oncology; 1985; 42(5):304-11. PubMed ID: 4034146
    [TBL] [Abstract][Full Text] [Related]  

  • 76. High susceptibility of p53(+/-) knockout mice in N-butyl-N-(4-hydroxybutyl)nitrosamine urinary bladder carcinogenesis and lack of frequent mutation in residual allele.
    Ozaki K; Sukata T; Yamamoto S; Uwagawa S; Seki T; Kawasaki H; Yoshitake A; Wanibuchi H; Koide A; Mori Y; Fukushima S
    Cancer Res; 1998 Sep; 58(17):3806-11. PubMed ID: 9731488
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Aspirin inhibition of N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide-induced lesions of the urinary bladder correlated with inhibition of metabolism by bladder prostaglandin endoperoxide synthetase.
    Cohen SM; Zenser TV; Murasaki G; Fukushima S; Mattammal MB; Rapp NS; Davis BB
    Cancer Res; 1981 Sep; 41(9 Pt 1):3355-9. PubMed ID: 6790163
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Metabolic fate and carcinogenicity of N-(omega-hydroxyalkyl) N-(4-hydroxybutyl) nitrosamines analogs of N-butyl-N-(4-hydroxy-butyl) nitrosamine, in the rat.
    Suzuki E; Takeda Y; Mochizuki M; Hashimoto Y; Okada M
    Gan; 1981 Aug; 72(4):539-46. PubMed ID: 7308665
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Transgenic rats carrying copies of the human c-Ha-ras proto-oncogene exhibit enhanced susceptibility to N-butyl-N-(4-hydroxybutyl)nitrosamine bladder carcinogenesis.
    Ota T; Asamoto M; Toriyama-Baba H; Yamamoto F; Matsuoka Y; Ochiya T; Sekiya T; Terada M; Akaza H; Tsuda H
    Carcinogenesis; 2000 Jul; 21(7):1391-6. PubMed ID: 10874018
    [TBL] [Abstract][Full Text] [Related]  

  • 80. neu is not involved in N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induced bladder carcinoma or 2-amino-4-(5-nitro-2-furyl)thiazole transformation of rat bladder epithelial cells.
    Mann AM; Asamoto M; Masui T; Macatee T; Eklund SH; Cohen SM
    Cancer Lett; 1994 Sep; 84(2):125-31. PubMed ID: 7915641
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.